Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colitis, Ulcerative × NX-13 × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Colitis, Ulcerative 1

Interventions

Specimen Handling 2 Nivolumab 2 Educational Status 2 pembrolizumab 1 Standard of Care 1 Practice Guidelines as Topic 1 NX-13 1 Methods 1 Interviews as Topic 1 Infliximab 1 Early Intervention, Educational 1 Colonoscopy 1 Biopsy 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05785715 2025-07-01

Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis

AbbVie

Phase 2 Terminated

Colitis, Ulcerative, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡